Intuitive Surgical, Inc. $ISRG Shares Bought by Atria Investments Inc

Atria Investments Inc lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 33,787 shares of the medical equipment provider’s stock after purchasing an additional 779 shares during the quarter. Atria Investments Inc’s holdings in Intuitive Surgical were worth $18,360,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Brighton Jones LLC lifted its stake in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the period. Golden State Wealth Management LLC raised its holdings in Intuitive Surgical by 13.7% during the first quarter. Golden State Wealth Management LLC now owns 1,757 shares of the medical equipment provider’s stock worth $870,000 after purchasing an additional 212 shares in the last quarter. Ameritas Advisory Services LLC boosted its stake in Intuitive Surgical by 5.9% during the 1st quarter. Ameritas Advisory Services LLC now owns 1,724 shares of the medical equipment provider’s stock valued at $878,000 after purchasing an additional 96 shares in the last quarter. Mather Group LLC. increased its position in shares of Intuitive Surgical by 26.2% during the 1st quarter. Mather Group LLC. now owns 2,771 shares of the medical equipment provider’s stock valued at $1,372,000 after purchasing an additional 576 shares during the period. Finally, DAVENPORT & Co LLC raised its stake in shares of Intuitive Surgical by 2.1% in the 1st quarter. DAVENPORT & Co LLC now owns 113,727 shares of the medical equipment provider’s stock worth $56,240,000 after buying an additional 2,302 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG stock opened at $537.59 on Thursday. The firm has a market capitalization of $192.72 billion, a P/E ratio of 71.11, a P/E/G ratio of 5.01 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company’s 50 day simple moving average is $461.96 and its 200-day simple moving average is $498.01.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the business posted $1.84 EPS. The company’s revenue was up 22.9% on a year-over-year basis. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Piper Sandler lifted their target price on Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Robert W. Baird set a $655.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 22nd. HSBC upped their price target on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Leerink Partners raised their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $608.92.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. This trade represents a 9.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 96,011 shares of company stock valued at $50,309,042 in the last ninety days. Company insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.